CAP RESEARCH is rated 3 out of 5 in the category pharmaceuticals. Read and write reviews about CAP RESEARCH. CAP RESEARCH is a CRO (Clinical Research Organization), specializing in recruitment optimization & streamlining clinical trials. Based in Mauritius, CAP RESEARCH is a one stop shop for medical development, pioneering clinical innovation in the southern hemisphere. We focus on early phase (healthy subjects and patients) drug development and phase II & III clinical trials. Mauritius offers unique benefits such as: - Strong legal and ethical framework; - Straight forward regulatory approval; - Hospital infrastructure and state-of-the-art private facilities; - Qualified medical doctors and Healthcare professionals. With a large population of untreated (naïve) patients of up to 50% diabetics alone (for example), Mauritius offers good patient recruitments rates. Combined with CAP RESEARCH’s strengths including: patient recruitment optimization, strong scientific leadership & expert team, high quality standards and parallel submission for study in France (through our partner Center CAP), we make the best and most cost-effective solution for medical development and clinical trials. At our state of the art facility, which includes a dedicated phase I unit with 20 beds, we focus on viral diseases: HCV, HBV, NASH, HIV; Diabetes & Oncology. For more information, feel free to contact us and to visit our website: www.cap-research.com
Address
Socota Phoenicia Sayed Hossen Road
Company size
11-50 employees
Headquarters
Phoenix, MAURITIUS